News from Cancer Discovery

• Neoadjuvant Pembrolizumab Takes on TNBC
  Preliminary results suggest that the PD-1 inhibitor plus chemo elicits a higher pCR rate than chemo alone.
• RNA Technologies Expand Tool Kit for Cancer Immunotherapy
  Novel platform for making vaccines and immunomodulatory factors shows promise in early-stage testing.
• Immunotherapy Shows Promise in Pancreatic Cancer
  T cell–based approach considered safe, generated responses in patients with advanced disease.